Attributes | Values |
---|
rdf:type
| |
description
| - clinical trial (en)
- ensayo clínico (es)
- ensayu clínicu (ast)
- klinisch onderzoek (nl)
- клінічне випробування (uk)
- կլինիկական փորձարկում (hy)
|
rdfs:label
| - A Study to Assess Safety, Tolerability, and PK of EDG-5506 in Healthy Volunteers and Becker Muscular Dystrophy Adults (en)
- A Study to Assess Safety, Tolerability, and PK of EDG-5506 in Healthy Volunteers and Becker Muscular Dystrophy Adults (nl)
|
skos:prefLabel
| - A Study to Assess Safety, Tolerability, and PK of EDG-5506 in Healthy Volunteers and Becker Muscular Dystrophy Adults (en)
- A Study to Assess Safety, Tolerability, and PK of EDG-5506 in Healthy Volunteers and Becker Muscular Dystrophy Adults (nl)
|
name
| - A Study to Assess Safety, Tolerability, and PK of EDG-5506 in Healthy Volunteers and Becker Muscular Dystrophy Adults (en)
- A Study to Assess Safety, Tolerability, and PK of EDG-5506 in Healthy Volunteers and Becker Muscular Dystrophy Adults (nl)
|
title
| |
title
| - A Phase 1, Randomized, Placebo-Controlled, Double-blind, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, PK and Food Effect of EDG-5506 in Adult Healthy Volunteers and Adults With Becker Muscular Dystrophy (en)
|
end time
| |
end time
| |
instance of
| |
instance of
| |
start time
| |
start time
| |
country
| |
country
| |
main subject
| |
main subject
| |
research site
| |
research site
| |
minimum age
| |
minimum age
| |
number of participants
| |
number of participants
| |
maximum age
| |
maximum age
| |
study type
| |
study type
| |
ClinicalTrials.gov ID
| |
ClinicalTrials.gov ID
| |
clinical trial phase
| |
clinical trial phase
| |
research subject recruitment status
| |
research subject recruitment status
| |
is about
of | |